pharmaphorum July 19, 2021
America’s biopharmaceutical industry says it is “ready to do its part” in building a stronger, more resilient, affordable, and equitable health care system for all.
COVID-19 highlighted both the challenges of the US healthcare system and the huge change potential of the country’s pharmaceutical industry.
Now, as vaccination continues at pace, the sector has pledged to help “build back better”, by lowering barriers between medical innovations and the patients who need them.
A new report by PhRMA, which represents the leading biopharmaceutical research companies in the US, said: “COVID-19 has…demonstrated that we need a healthcare system that works better for all patients, and is better prepared for future public health emergencies.
“The substantial challenges faced by states and local public...
Today's Sponsors
Today's Sponsor